Liminal BioSciences Inc. LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc.

Bullboard Posts

Post by mmaltaison Jun 09, 2018 7:59am

149 Views

Post# 28149442

Macquarie last month

Broker Positions for C:PLI Broker #11 from 20180508 to 20180608

Date	Sold	$Val	Ave	Net	Position	$Net	$Position
20180604	122,000	97,701	0.801	-122,000	-122,000	97,701	97,701
20180606	531,500	417,380	0.785	-531,500	-653,500	417,380	515,081
20180608	500,000	366,014	0.732	-500,000	-1,153,500	366,014	881,095
TOTAL	1,153,500	881,095	0.764		-1,153,500		881,095